This is a reminder notice that your options to subscribe for ordinary fully paid shares in Queensland Bauxite Limited (ASX:QBL) will expire at 5:00pm Australian Western Standard Time on 31 July 2017.
Queensland Bauxite Ltd
Queensland Bauxite Limited (ASX:QBL) is an Australian listed company focused on the exploration and development of its bauxite tenements in Queensland and New South Wales. The Company's lead project is the South Johnstone Bauxite Deposit in northern Queensland which has rail running through the project area and is approximately 15-24 kilometres from the nearest deep water port. The Company intends to become a bauxite producer with a focus on commencing production at South Johnstone as early as possible. The Company also pursues additional investment opportunities, and has acquired a 55% shareholding in Medical Cannabis Limited, an Australian leader in the hemp and Cannabis industries.
Queensland Bauxite Ltd (ASX:QBL) is excited to announce that Medical Cannabis Limited has confirmed successful germination and growth rates of its pioneering winter Cannabis crop.
It has come the attention of Queensland Bauxite Ltd (ASX:QBL) that there has been some confusion between Andrew Kavasilas of Medical Cannabis Limited and Andrew Katelaris. Andrew Katelaris, Dr Pot, allegedly caught last week with cash and cannabis, and consequently arrested, is NOT the Andrew Kavasilas of Medical Cannabis Limited.
The directors of Queensland Bauxite Ltd (ASX:QBL) are excited to inform our shareholders that completion of the acquisition of 55% of MCL has occurred today with the issue of 49 million shares in QBL to the shareholders of MCL.
As the directors of Medical Cannabis Limited (MCL) are drafting a prospectus for an independent ASX listing of MCL, the Board of MCL in conjunction with the QBL (ASX:QBL) Board, have decided that the MCL Initial Public Offering (IPO) will be giving Queensland Bauxite shareholders preference to take up shares in the anticipated MCL Listing on ASX.
Queensland Bauxite Ltd (ASX:QBL) Andrew Kavasilas Interview Regarding Medical Cannabis Limited and Vitahemp
Andrew Kavasilas, Technical Director of Medical Cannabis Limited (MCL), has been interviewed by 2Ser 107.3 in relation to the work that he has been doing with Medical Cannabis Limited and Vitahemp, and in preparation for the upcoming Hemp Health and Innovation Expo, Australia's largest Cannabis Expo. Andrew also discussed general information on the industry and Cannabis.
On the 10th March 2017, Andrew Kavasilas, Director of Medical Cannabis Limited received permission from the Department of Primary Industries to start an indoor grow project of low THC Cannabis, in preparation for the Hemp & Health Innovation Expo in May as a continuation of the Company's existing Cannabis growing and research project.
Following yesterday's announcement, Andrew Kavasilas of Vitahemp Pty Ltd has met with a Senior Policy Adviser from the Department of Primary Industries in NSW, where they discussed various initiatives that will help to develop and establish Trade and Industry Standards in relation to the newly approved Australian grown hemp seed food market.
Queensland Bauxite Ltd (ASX:QBL) Meetings with the Department of Environment and Heritage Protection and Department of Infrastructure, Local Government and Planning
On Friday 3rd May and Monday 6th May, Queensland Bauxite Limited (ASX:QBL) had productive and positive meetings with officers of the Department of Environment and Heritage Protection in Cairns and the Department of Infrastructure, Local Government and Planning in Brisbane.
Andrew Kavasilas, Technical Director of Vitahemp and Medical Cannabis Limited will be meeting this morning with a senior policy advisor from the Department of Primary Industries, at the cabinet office, to provide his assistance to the DPI in developing the detailed components of the newly approved decision.